title: Oral propranolol therapy for management of exudative retinal detachment from diffuse choroidal hemangioma in Sturge-Weber syndrome.
abstract: OBJECTIVE
  Diffuse choroidal hemangioma (DCH), a feature of Sturge-Weber syndrome, is most often treated with whole-eye radiotherapy at stage of complications such as retinal detachment.
  
  
  METHODS
  This is a case report of a 17-year-old boy with DCH and exudative retinal detachment.
  
  
  RESULTS
  The patient was treated with propranolol at 60 mg twice a day for 2 months followed by gradual dose taper to 10 mg twice a day per month and discontinued at 7 months. The retinal detachment slowly resolved over 1 month and the retina remained attached at 10 months follow-up. There were no medication side effects.
  
  
  CONCLUSIONS
  We suggest that oral propranolol be considered in the armamentarium for selected DCH.
authors.affiliation: Tilganga Institute of Ophthalmology, Kathmandu - Nepal. rabathapa@live.com
authors.forename: Raba
authors.initials: R
authors.lastname: Thapa
authors.forename: Carol L
authors.initials: CL
authors.lastname: Shields
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002830:Choroid Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005122:Exudates and Transudates; D005451:Fluorescein Angiography; D006391:Hemangioma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D064847:Multimodal Imaging; D011433:Propranolol / Q000627:therapeutic use*; D012163:Retinal Detachment / Q000188:drug therapy* / Q000209:etiology; D013341:Sturge-Weber Syndrome / Q000150:complications*; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol